[PDF][PDF] Effective Leadership through Bioentrepreneurship and Bioinnovation

C Kearney, LJ Langer - Journal of Commercial Biotechnology, 2018 - academia.edu
Biotechnology firms need leaders that can lead scientists beyond the science and turn new
discoveries into commercially viable products. Bioentrepreneurial leaders are continuous …

[引用][C] Biotech companies just can't get the staff these days

A Michael - Nature Biotechnology, 1998 - nature.com
A new company that will supply board members giving strategic and philosophical advice to
European bioscience firms was created in London at the start of August. Ziggus Holdings …

Biotechnology: identifying advances from the hype

RH Glassman, AY Sun - Nature Reviews Drug Discovery, 2004 - nature.com
Biotechnology has established itself as one of the most promising, exciting sectors in our
economy: its talent base is among the'best and the brightest'; it receives large amounts of …

Biotechnology: why is Europe lagging behind the US?

G Owen - LSE Business Review, 2016 - eprints.lse.ac.uk
Biotechnology: Why is Europe lagging behind the US? Page 1 12/07/2017 Biotechnology:
Why is Europe lagging behind the US? | LSE Management http://blogs.lse.ac.uk/management/2016/11/07/biotechnology-why-is-europe-lagging-behind-the-us …

Science Business: The Promise, the Reality and the Future of Biotech

W Li - Journal of Commercial Biotechnology, 2007 - Springer
© 2007 PALGRAVE MACMILLAN LTD 1462-8732 $30.00 JOURNAL OF COMMERCIAL
BIOTECHNOLOGY. VOL 13. NO 4. 315–317 AUGUST 2007 316 2–3 cycles of new product …

Critical success factors for biotechnology industry in Canada

S Vanderbyl, S Kobelak - Journal of Commercial Biotechnology, 2007 - Springer
Critical success factors and performance indicators provide the biotechnology industry with
a foundation on which to grow and manage risks. In a recent survey of 247 biotechnology …

Spin-offs versus start-ups as business models in biotechnology

A Persidis, F De Rubertis - Nature Biotechnology, 2000 - nature.com
NATURE BIOTECHNOLOGY VOL 18 MAY 2000 http://biotech. nature. com 571 additional
contributions that more patents issued, enhanced pipelines, and a number of strategic …

Cloning an industry: Strategy typologies of Shanghai biotechnology companies

K Malone, B Hales, J Chan, M Love… - Journal of Commercial …, 2008 - Springer
Insight into the development of the medicinal biotechnology sector of China is provided
through interviews of 19 Shanghai-based companies. Two commonly accepted strategy …

Ten keys to successful technology commercialization

SS Donovan - Industrial Biotechnology, 2006 - liebertpub.com
• Tolerate calculated risks• Nurture a supportive, collaborative, and fear-free environment•
Utilize fully the talents of all employees• Use the carrot artfully, and use the stick sparingly …

[图书][B] Biotech industry: A global, economic, and financing overview

B Bergeron, P Chan - 2004 - books.google.com
" The biotech industry is a complex, rapidly evolving, and critical industry. The industry holds
great commercial and societal promise, but it is also filled with hype, confusion, and risks …